Therapeutic Apheresis and Dialysis
© International Society for Apheresis

Edited By: Tadao Akizawa, Wolfgang Ramlow, A. Sergio Torloni, Akio Kawamura, Eiji Kusano, Paul S. Malchesky, Angela T. Hadsell
Impact Factor: 1.391
ISI Journal Citation Reports © Ranking: 2011: 49/73 (Urology & Nephrology); 51/68 (Hematology)
Online ISSN: 1744-9987
Recently Published Issues
Current Issue:April 2013
Volume 17, Issue 2
Volume 17, Issue Supplement S1
Special Issue: Clinical findings of Lanthanum carb...
Volume 17, Issue 1
Volume 16, Issue 6
Volume 16, Issue 5
Become a Reviewer
Become a reviewer for Therapeutic Apheresis and Dialysis, the official journal of the International Society for Apheresis, the Japanese Society for Apheresis and the Japanese Society for Dialysis Therapy.
If you are interested in becoming a Reviewer for the journal, please complete and send this form to the Editorial Office (TherApherDial@aol.com) or visit the Online Submission and Review System and create an account.
Most Cited Articles
Role of Oxidative Stress and Indoxyl Sulfate in Progression of Cardiovascular Disease in Chronic Kidney Disease
Hideki Fujii, Kentaro Nakai, et al.
Coronary Plaque Morphology Using Virtual Histology–Intravascular Ultrasound Analysis in Hemodialysis Patients
Keiji Kono, Hideki Fujii, et al.
Simple Cystatin C Formula Compared to Sophisticated CKD-EPI Formulas for Estimation of Glomerular Filtration Rate in the Elderly
Sebastjan Bevc, Radovan Hojs, et al.
Free Editor's Choice Articles
Hepcidin is a Potential Regulator of Iron Status in Chronic Kidney Disease
Ken Tsuchiya and Kosaku Nitta
Click here to read a brief introduction by the author
Parathyroid Enlargement at Dialysis Initiation in Patients With Chronic Kidney Diseases
Kentaro Nakai, Hideki Fujii, et al.
Click here to read a brief introduction by the author
Survey of the Effects of a Column for Adsorption of β2-Microglobulin in Patients With Dialysis-Related Amyloidosis in Japan
Fumitake Gejyo, Izumi Amano, et al.
Click here to read a brief introduction by the author
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)
Shigeru Nakai, Kunitoshi Iseki, et al.
High Target Hemoglobin With Erythropoiesis-Stimulating Agents Has Advantages in the Renal Function of Non-Dialysis Chronic Kidney Disease Patients
Yoshiharu Tsubakihara, Fumitake Gejyo, et al.
2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients
Takashi Akiba, Kazuhiko Hora, et al.
Immunoadsorption in Dermatology
Damian Meyersburg, Enno Schmidt, et al.
Hemodialysis Vascular Access Dysfunction: Molecular Mechanisms and Treatment
Akira Mima
Occult Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for Consideration
Arezoo Aghakhani, Mohammad, et al.
Effects of In-Center Nocturnal Versus Conventional Hemodialysis on Endothelial Dysfunction
Xiucai Jin, Shu Rong, et al.
Sarcomatoid Carcinoma in the Native Kidney of a Renal Transplant Recipient
Toshihiro Kitajima, Yoshifumi Ubara, et al.
My Experiences With Apheresis
Leo J McCarthy
Brachial-Ankle Pulse Wave Velocity and the Cardio-Ankle Vascular Index as a Predictor of Cardiovascular Outcomes in Patients on Regular Hemodialysis
Akihiko Kato, Takako Takita, et al.
Effect of Alfacalcidol Therapy on the Survival of Chronic Hemodialysis Patients
Mariko Ogawa, Tetsuya Ogawa, et al.
Cardiovascular Protective Effects of On-Line Hemodiafiltration: Comparison With Conventional Hemodialysis
Takayasu Ohtake, Machiko Oka, et al.
Late Dialysis Start Did Not Affect Long-Term Outcome in Japanese Dialysis Patients: Long-Term Prognosis From Japanese Society of Dialysis Therapy Registry
Kunihiro Yamagata, Shigeru Nakai, et al.
News
Increased Impact Factor 1.391 !
Read, cite the journal or submit to keep contributing to the success of Therapeutic Apheresis and Dialysis.
Click here to access the TOP cited articles published in 2011-2012.

1744-9987/asset/TAP_left.gif?v=1&s=7d875b016e0b3276e36e8e680437a2e08aa2af1d)
1744-9987/asset/TAP_right.gif?v=1&s=cfcdd17dd618cfdddf584eaf319e437572c8768b)
1744-9987/asset/defaultSocietyImage.jpg?v=1&s=c1d4d0320e180f9ac25888a4d9a51813b98e3fbc)